Clinical trials with oncolytic measles virus: Current status and future prospects

Keyphrases

• Virus 100%
• Clinical Trials 100%
• Breast Cancer 100%
• Oncolytic 100%
• Oncolytic Measles Virus 100%
• Clinically Significant 50%
• Cancer Cells 50%
• Ovarian Cancer 50%
• Multiple Myeloma 50%
• Head-and-neck Cancer 50%
• Lysis 50%
• Preclinical Data 50%
• Genetic Engineering 50%
• Measles Virus 50%
• Carcinoembryonic Antigen 50%
• Clinical Translation 50%
• Mesothelioma 50%
• Glioblastoma multiforme 50%
• Malignant Peripheral Nerve Sheath Tumor (MPNST) 50%
• Vaccine Strain 50%
• Vector Development 50%
• Human Sodium Iodide Symporter (hNIS) 50%
• VsCEP 50%
• Creative Strategy 50%
• MV-NIS 50%
• Development Strategy 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Carcinoembryonic Antigen 100%
• Measles Virus 100%
• Malignant Neoplasm 50%
• Glioblastoma 50%
• Multiple Myeloma 50%
• Breast Cancer 50%
• Head and Neck Cancer 50%
• Ovary Cancer 50%
• Mesothelioma 50%
• Malignant Peripheral Nerve Sheath Tumor 50%
• Vaccine Strain 50%
• Sodium Iodide Symporter 50%